Anlotinib in combination with trifluridine-tipiracil in patients with refractory metastatic colorectal cancers: a phase II, single arm study

Authors

Institutions

Publication Details

Journal
The Oncologist
Published
2026-02-05
DOI
https://doi.org/10.1093/oncolo/oyag019
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anlotinib in combination with trifluridine-tipiracil in patients with refractory metastatic colorectal cancers: a phase II, single arm study

C. Zhang, xiaojing xu, Mengling Liu, Qing Liu et al.
The Oncologist
Lung Cancer Research Studies
article

Anlotinib in combination with trifluridine-tipiracil in patients with refractory metastatic colorectal cancers: a phase II, single arm study

C. Zhang, xiaojing xu, Mengling Liu, Qing Liu, Tianshu Liu, Peng Ke, Yiyi Yu
article en

Abstract

No abstract available for this paper.
The OncologistVol. 31(3)
Shanghai Medical College of Fudan University (CN), Fudan University (CN), Fudan University Shanghai Cancer Center (CN), Zhongshan Hospital (CN)
Good health and well-being
Openalex Percentile: Top 46%
Lung Cancer Research Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.